Patrapim Sunpaweravong1,2, Kelsie L Thu3, Wan L Lam3, Sabine Mai4. 1. Genomic Centre for Cancer Research and Diagnosis, Manitoba Institute of Cell Biology, University of Manitoba, 675 McDermot Avenue, Room ON6045, Winnipeg, MB, Canada. 2. Division of Medical Oncology, Department of Medicine, Prince of Songkla University, Songkhla, Thailand. 3. Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada. 4. Genomic Centre for Cancer Research and Diagnosis, Manitoba Institute of Cell Biology, University of Manitoba, 675 McDermot Avenue, Room ON6045, Winnipeg, MB, Canada. Sabine.Mai@umanitoba.ca.
Abstract
PURPOSE: To identify potential biomarkers that may provide new therapeutic targets or prognostic indicators for non-small cell lung cancer (NSCLC), we investigated the three-dimensional (3D) organization of telomeres and cytoband 17q25.3 copy number in NSCLC tissues. METHODS: NSCLC paraffin-embedded tissue specimens from 18 patients were assessed for 3D telomere organization by 3D nuclear telomere imaging followed by quantitative analysis. Patients were stratified by smoking, histology, and EGFR status. Cytoband 17q25.3 was examined by fluorescent in situ hybridization. Data from comparative genomic hybridization and/or single nucleotide polymorphism arrays for cytoband 17q25.3 were obtained and correlated with Q-FISH and 3D telomere results. RESULTS: 3D telomeric profiling demonstrated that the smokers, EGFR-negative, and squamous cell carcinoma subgroups tended to have higher numbers of lower-intensity telomeres, indicative of shorter telomeres, as well as higher numbers of telomeric aggregations compared to non-smokers, EGFR-positive, and adenocarcinomas, respectively. Gains of cytoband 17q25.3 in conjunction with an increase in the control region 17p11.2 were observed in 7 of 18 (38.9 %) patients, reflecting a gain of chromosome 17. Clonal gains of cytoband 17q25.3 were observed in 11 of 18 (61 %) patients, highlighting a potential biological significance for the genes in this region in NSCLC tumourigenesis. CONCLUSIONS: The 3D telomere profiles may differentiate NSCLC patients with different histologies, EGFR, and smoking statuses, rendering them a potential biomarker for distinguishing these clinically relevant histological and molecular subtypes of lung cancer. Highly frequent clonal gain of cytoband 17q25.3 was also demonstrated, suggesting an important biological role for the genes in this region.
PURPOSE: To identify potential biomarkers that may provide new therapeutic targets or prognostic indicators for non-small cell lung cancer (NSCLC), we investigated the three-dimensional (3D) organization of telomeres and cytoband 17q25.3 copy number in NSCLC tissues. METHODS:NSCLCparaffin-embedded tissue specimens from 18 patients were assessed for 3D telomere organization by 3D nuclear telomere imaging followed by quantitative analysis. Patients were stratified by smoking, histology, and EGFR status. Cytoband 17q25.3 was examined by fluorescent in situ hybridization. Data from comparative genomic hybridization and/or single nucleotide polymorphism arrays for cytoband 17q25.3 were obtained and correlated with Q-FISH and 3D telomere results. RESULTS: 3D telomeric profiling demonstrated that the smokers, EGFR-negative, and squamous cell carcinoma subgroups tended to have higher numbers of lower-intensity telomeres, indicative of shorter telomeres, as well as higher numbers of telomeric aggregations compared to non-smokers, EGFR-positive, and adenocarcinomas, respectively. Gains of cytoband 17q25.3 in conjunction with an increase in the control region 17p11.2 were observed in 7 of 18 (38.9 %) patients, reflecting a gain of chromosome 17. Clonal gains of cytoband 17q25.3 were observed in 11 of 18 (61 %) patients, highlighting a potential biological significance for the genes in this region in NSCLC tumourigenesis. CONCLUSIONS: The 3D telomere profiles may differentiate NSCLCpatients with different histologies, EGFR, and smoking statuses, rendering them a potential biomarker for distinguishing these clinically relevant histological and molecular subtypes of lung cancer. Highly frequent clonal gain of cytoband 17q25.3 was also demonstrated, suggesting an important biological role for the genes in this region.
Entities:
Keywords:
(non)Smoking; 3D telomere profiles; Chromosome 17q gain; EGFR; Non-small cell lung cancer
Authors: B J Vermolen; Y Garini; S Mai; V Mougey; T Fest; T C-Y Chuang; A Y-C Chuang; L Wark; I T Young Journal: Cytometry A Date: 2005-10 Impact factor: 4.355
Authors: Macoura Gadji; Julius Adebayo Awe; Prerana Rodrigues; Rajat Kumar; Donald S Houston; Ludger Klewes; Tandakha Ndiaye Dièye; Eduardo Magalhães Rego; Roberto Falcão Passetto; Fábio Morato de Oliveira; Sabine Mai Journal: Clin Cancer Res Date: 2012-04-26 Impact factor: 12.531
Authors: Jin Soo Choi; Long Tai Zheng; Eunyoung Ha; Yun Jeong Lim; Yeul Hong Kim; Young-Pil Wang; Young Lim Journal: Lung Date: 2006-11-03 Impact factor: 2.584
Authors: Wei Jie Seow; Richard M Cawthon; Mark P Purdue; Wei Hu; Yu-Tang Gao; Wen-Yi Huang; Stephanie J Weinstein; Bu-Tian Ji; Jarmo Virtamo; H Dean Hosgood; Bryan A Bassig; Xiao-Ou Shu; Qiuyin Cai; Yong-Bing Xiang; Shen Min; Wong-Ho Chow; Sonja I Berndt; Christopher Kim; Unhee Lim; Demetrius Albanes; Neil E Caporaso; Stephen Chanock; Wei Zheng; Nathaniel Rothman; Qing Lan Journal: Cancer Res Date: 2014-05-22 Impact factor: 12.701
Authors: Tony Chih Yuan Chuang; Sharareh Moshir; Yuval Garini; Alice Ya-Chun Chuang; Ian T Young; Bart Vermolen; Richard van den Doel; Virginie Mougey; Mathilde Perrin; Martina Braun; Paul Donald Kerr; Thierry Fest; Petra Boukamp; Sabine Mai Journal: BMC Biol Date: 2004-06-03 Impact factor: 7.431
Authors: Travis I Zack; Stephen E Schumacher; Scott L Carter; Andre D Cherniack; Gordon Saksena; Barbara Tabak; Michael S Lawrence; Cheng-Zhong Zhsng; Jeremiah Wala; Craig H Mermel; Carrie Sougnez; Stacey B Gabriel; Bryan Hernandez; Hui Shen; Peter W Laird; Gad Getz; Matthew Meyerson; Rameen Beroukhim Journal: Nat Genet Date: 2013-10 Impact factor: 38.330